[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Atossa Therapeutics Inc (ATOS)

Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Atossa Therapeutics Inc 1448 NW Market Street Suite 500 SEATTLE WA 98107 USA

www.atossatherapeutics.com Employees: 14 P: 206-588-0256

Sector:

Medical

Description:

Atossa Therapeutics Inc. is a clinical-stage biopharmaceutical company develops medicines in areas of significant unmet medical need in oncology principally in the United States. Its lead drug candidate is oral (Z)-endoxifen. Atossa Therapeutics Inc., formerly known as Atossa Genetics Inc., is based in Seattle, Washington.

Key Statistics

Overview:

Market Capitalization, $K 25,547
Enterprise Value, $K -15,863
Shares Outstanding, K 9,979
Float, K 9,001
% Float 90.20%
Short Interest, K 776
Short Float 9.02%
Days to Cover 4.66
Short Volume Ratio 0.42
% of Insider Shareholders 9.80%
% of Institutional Shareholders 12.74%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -34,770 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -8,490 K
EBIT, $ -39,250 K
EBITDA, $ -39,230 K

Growth:

1-Year Return -77.78%
3-Year Return -80.82%
5-Year Return -94.76%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 86.32%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.95 on 08/07/26
Next Earnings Date 11/11/26
Earnings Per Share ttm -3.11
EPS Growth vs. Prev Qtr 14.41%
EPS Growth vs. Prev Year 9.48%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 02/02/26

ATOS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -94.57%
Return-on-Assets % -78.80%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.66
Book Value/Share 3.12
Interest Coverage -1.18
60-Month Beta 1.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.